10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001144204-12-059142`
Period End Date	20120930
Filing Date	20121102
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	heb-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 9 Cash Flow Statement 64 Stockholders Equity 2 Comprehensive Income 68

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.02M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.16M	USD	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$21.90M	USD	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$26.23M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities- restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$10.34M	USD	Point-in-time
Marketable securities- restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$1.03M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventories	`InventoryWorkInProcess`	$787.00K	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	$799.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventories	`InventoryWorkInProcess`	$897.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	135.64M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$257.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	147.51M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$531.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	147.51M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	135.64M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$31.79M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$36.45M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.28M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.33M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$947.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$863.00K	USD	Point-in-time
Marketable securities - unrestricted	`AvailableForSaleSecuritiesNoncurrent`	-	USD	Point-in-time
Marketable securities - unrestricted	`AvailableForSaleSecuritiesNoncurrent`	$1.96M	USD	Point-in-time
Marketable securities - restricted	`AvailableforsaleSecuritiesRestrictedNoncurrent`	$2.08M	USD	Point-in-time
Marketable securities - restricted	`AvailableforsaleSecuritiesRestrictedNoncurrent`	-	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$1.48M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$5.79M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$71.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$65.00K	USD	Point-in-time
Total assets	`Assets`	$48.58M	USD	Point-in-time
Total assets	`Assets`	$43.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.34M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.68M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.64M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.64M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$5.76M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$1.70M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$49.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$49.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.79M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$64.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$99.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$380.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$2.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.97M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.55M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 147,508,498 and 135,642,303, respectively	`CommonStockValue`	$136.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 147,508,498 and 135,642,303, respectively	`CommonStockValue`	$148.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$274.67M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$264.96M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-389.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$428.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-226.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-238.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.97M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$43.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$48.58M	USD	Point-in-time

Income Statement 9 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.61M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.97M	USD	Point-in-time
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$9.27M	USD	3 Qtrs
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$262.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$195.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$348.00K	USD	3 Qtrs
Net comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-11.08M	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.61M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.97M	USD	Point-in-time

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-5.90M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-6.59M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.74M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.89M	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$322.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$469.00K	USD	3 Qtrs
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$29.00K	USD	3 Qtrs
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$161.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$614.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$-1.73M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.56M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$-1.97M	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$195.00K	USD	3 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$348.00K	USD	3 Qtrs
Other than temporary impairment of marketable securities	`MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount`	$258.00K	USD	3 Qtrs
Inventory Reserve	`InventoryLIFOReserveEffectOnIncomeNet`	$778.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$680.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$302.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$93.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-274.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$925.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$319.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-629.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-8.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.18M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.07M	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.82M	USD	3 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$849.00K	USD	3 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$92.00K	USD	3 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$113.00K	USD	3 Qtrs
Deposits on capital leases refunded (paid)	`PaymentsToAcquireEquipmentOnLease`	$4.00K	USD	3 Qtrs
Deposits on capital leases refunded (paid)	`PaymentsToAcquireEquipmentOnLease`	$-6.00K	USD	3 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$13.38M	USD	3 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$11.15M	USD	3 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$3.13M	USD	3 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$13.52M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$7.07M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.06M	USD	3 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$50.00K	USD	3 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$35.00K	USD	3 Qtrs
Proceeds from margin account loan	`ProceedsFromMarginAccountLoan`	$4.07M	USD	3 Qtrs
Proceeds from margin account loan	`ProceedsFromMarginAccountLoan`	$1.16M	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.27M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.11M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.30M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$55.00K	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.10M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.02M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.02M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.16M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$71.00K	USD	3 Qtrs
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$262.00K	USD	3 Qtrs
Equipment acquired by capital lease	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$62.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$107.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$890.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$-1.56M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$1.73M	USD	3 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$68.00K	USD	3 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$21.00K	USD	3 Qtrs

Stockholders Equity 2 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time

Comprehensive Income 68 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$123.00K	USD	3 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$45.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$39.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$160.00K	USD	3 Qtrs
Total Revenues	`Revenues`	$39.00K	USD	1 Quarter
Total Revenues	`Revenues`	$45.00K	USD	1 Quarter
Total Revenues	`Revenues`	$160.00K	USD	3 Qtrs
Total Revenues	`Revenues`	$123.00K	USD	3 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$217.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$1.48M	USD	3 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$988.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$614.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.76M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.36M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.01M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.75M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.64M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.89M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.66M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.27M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$10.52M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$12.51M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$5.00M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.60M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.56M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-12.35M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.96M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-10.39M	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$19.00K	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$21.00K	USD	3 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$7.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$9.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$353.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$686.00K	USD	3 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$212.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$873.00K	USD	3 Qtrs
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$-1.33M	USD	3 Qtrs
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$-2.27M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$614.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$-1.73M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.56M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$-1.97M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.90M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-6.59M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.74M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.89M	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$890.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-402.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-543.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$306.00K	USD	1 Quarter
Realized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$14.00K	USD	1 Quarter
Realized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-168.00K	USD	1 Quarter
Realized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-205.00K	USD	3 Qtrs
Realized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$509.00K	USD	3 Qtrs
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$24.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$132.00K	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.79M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-6.42M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.27M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-11.08M	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	137.01M	shares	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.50M	shares	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	136.26M	shares	3 Qtrs
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.38M	shares	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.